Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.03B |
| 2 |
McDonald's
MCD
|
+$609M |
| 3 |
UnitedHealth
UNH
|
+$598M |
| 4 |
Strategy Inc
MSTR
|
+$514M |
| 5 |
Qualcomm
QCOM
|
+$469M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.14B |
| 2 |
NVIDIA
NVDA
|
+$1.53B |
| 3 |
Eli Lilly
LLY
|
+$1.08B |
| 4 |
Mastercard
MA
|
+$996M |
| 5 |
Uber
UBER
|
+$932M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.27% |
| 2 | Consumer Discretionary | 12.49% |
| 3 | Financials | 11.57% |
| 4 | Healthcare | 9.6% |
| 5 | Communication Services | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Eve Holding
EVEX
$798M
| $204K | ﹤0.01% |
+27,485
| New | +$122K |
|
1527
Grupo Aeroportuario Centro Norte
OMAB
$4.99B
| $203K | ﹤0.01% |
1,870
+481
| +35% | +$45.1K |
|
|
BBT
1528
Beacon Financial Corp
BBT
$2.53B
| $201K | ﹤0.01% |
7,596
-9,871
| -57% | -$245K |
|
1529
Globe Life
GL
$13.5B
| $201K | ﹤0.01% |
1,668
-177,089
| -99% | -$21.5M |
|
1530
US Physical Therapy
USPH
$1.14B
| $201K | ﹤0.01% |
2,486
-3,667
| -60% | -$270K |
|
1531
Hess Midstream
HESM
$5.22B
| $200K | ﹤0.01% |
5,215
-1,752
| -25% | -$66.7K |
|
1532
Helix Energy Solutions
HLX
$1.46B
| $200K | ﹤0.01% |
30,416
-40,553
| -57% | -$269K |
|
1533
The RealReal
REAL
$1.34B
| $197K | ﹤0.01% |
+37,622
| New | +$207K |
|
1534
Clean Energy Fuels
CLNE
$447M
| $197K | ﹤0.01% |
94,235
-1,990
| -2% | -$3.38K |
|
1535
Pediatrix Medical
MD
$2.16B
| $197K | ﹤0.01% |
14,270
-20,332
| -59% | -$279K |
|
1536
Macy's
M
$6.15B
| $195K | ﹤0.01% |
15,586
-36
| -0.2% | -$417 |
|
|
DVAX
1537
DELISTED
Dynavax Technologies
DVAX
| $193K | ﹤0.01% |
19,041
-30,472
| -62% | -$321K |
|
|
PMT
1538
PennyMac Mortgage Investment
PMT
$849M
| $193K | ﹤0.01% |
14,588
-20,827
| -59% | -$265K |
|
1539
Varex Imaging
VREX
$460M
| $191K | ﹤0.01% |
21,900
+19,423
| +784% | +$158K |
|
1540
Northwest Bancshares
NWBI
$2.25B
| $190K | ﹤0.01% |
14,239
| – | – |
|
1541
Tandem Diabetes Care
TNDM
$1.17B
| $188K | ﹤0.01% |
11,022
-14,162
| -56% | -$280K |
|
|
TWO
1542
Two Harbors Investment
TWO
$1.27B
| $188K | ﹤0.01% |
17,081
-749,652
| -98% | -$8.45M |
|
1543
Gevo
GEVO
$397M
| $181K | ﹤0.01% |
128,484
-2,315
| -2% | -$2.71K |
|
1544
iShares MSCI Indonesia ETF
EIDO
$476M
| $175K | ﹤0.01% |
10,000
-78,400
| -89% | -$1.37M |
|
|
VISN
1545
Vistance Networks Inc
VISN
$2.66B
| $171K | ﹤0.01% |
20,611
-6,527
| -24% | -$34.2K |
|
1546
Redwire
RDW
$2.08B
| $171K | ﹤0.01% |
+10,931
| New | +$142K |
|
1547
N-able
NABL
$769M
| $168K | ﹤0.01% |
20,518
-21,206
| -51% | -$158K |
|
|
UNIT
1548
Uniti Group
UNIT
$2.63B
| $168K | ﹤0.01% |
38,226
-55,363
| -59% | -$249K |
|
1549
Stoneridge
SRI
$209M
| $166K | ﹤0.01% |
21,398
| – | – |
|
1550
QuantumScape Corp
QS
$3B
| $162K | ﹤0.01% |
23,799
-70,714
| -75% | -$299K |
|
Similar funds
Amundi's Q2 2025 Portfolio in Review
As of Q2 2025, Amundi held 2,245 positions worth $290B, up 5.5% from $275B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Amundi withdrew a net $25.8B in Q2 2025, closing 579 positions and reducing 831 holdings. Its most notable exit was Novo Nordisk, an estimated $332M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Amundi opened a new position in Victory Capital Holdings worth $213M.
- Amundi's largest Q2 2025 buy was Victory Capital Holdings: 3,293,471 shares worth $213M.
- Amundi added most to Tesla in Q2 2025, an estimated $1.03B increase.
- Amundi's biggest Q2 2025 reduction was Microsoft, cutting an estimated $3.14B.
- Amundi fully exited Novo Nordisk in Q2 2025, selling an estimated $332M.
- Amundi's ten largest holdings make up 31% of its $290B portfolio in Q2 2025.
- Amundi opened 66 new positions and closed 579 in Q2 2025.
- Amundi's portfolio value rose 5.5% quarter-over-quarter to $290B.
Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.